期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非小细胞肺癌化疗及分子靶向治疗药物的研究进展 被引量：8

Development in chemotherapy and molecular targeted drugs of NSCLS
下载PDF
导出
摘要 非小细胞肺癌(NSCLC)在全世界范围的发病率逐年上升,对人类健康造成严重威胁。经过多年努力,NSCLC的治疗效果明显提高。本文就近年来NSCLC化疗及分子靶向治疗等方面的研究进展加以综述。 Non-small ceil lung cancer incidence in the world has gradually increased,it is a serious threat to human health. The treatment of NSCLC has significantly increased in the recent years. This article summarized the latest developments in chemotherapy and molecular targeted therapy of non-small cell lung cancer.
作者 刘洋 吴荣
机构地区 中国医科大学附属盛京医院第二肿瘤科病房
出处 《实用药物与临床》 CAS 2009年第4期272-275,共4页 Practical Pharmacy and Clinical Remedies
关键词 非小细胞肺癌 化疗 分子靶向治疗药物 Non-small cell lung cancer chemotherapy Molecular targeted drugs
分类号 R979.1 [医药卫生—药品]
  • 相关文献

参考文献22

  • 1Scagliotti G, Pastorino U, Vansteenkiste J, et al. A phase Ⅲ randomized study of surgery alone or surgery plus preoperative gemcitabine - cisplatin in early-stage non - small cell lung cancer ( NSCLC ) : follow-up data of Ch.E. S. T [ J ]. J Clin Oncol,2008,26 (S) :7508.
  • 2Pisters K,Vallieres E,Bunn PA,et al. S9900:Surgery alone or surgery plus induction ( ind ) paclitaxel/carboplatin ( PC ) chemotherapy in early stage non-small cell lung cancer (NSCLC) :Follow-up on a phase Ⅲ trial[ J]. J Clin Oncol, 2007,25(18S) :7520.
  • 3Le Chevalier T, Dunant A, Arriaggada R, et al. Long - term results of the International Adjuvant Lung Cancer Trial (IALT) evaluation adjuvant cisplatin - based chemotherapy in resected non-small cell lung cancer (NSCLC) [J]. J Clin Oncol,2008,26 (S) :7507.
  • 4Taso MS, Zhu C, Ding K, et al. A 15-gene expression signature prognostic for survival prognostic for survival and predictive for adjuvant chemotherapy benefit in JBR. 10 patient [ J ]. J Clin Oncol,2008,26(S) :7510.
  • 5EI-Shenshawy HM, Fathy A, Eteba S, et al. Sequential chemoradiotherapy versus concurrent chemoradiotherapy PLUS comsodidation chenmotherapy in unresectable stage Ⅲ non-small cell lung cancer[ J]. J Clin Oncol,2008,26(S) :8509.
  • 6Mina LA, Neeubauer MA, Ansafi RH, et al. Phase III trial of cisplatin (P) plus etoposid (E) plus concurrent chest radia- tion (CRT) in patient (PTS) with or without consolidation docetaxel(D) in patients(pts) with inoperable stage Ⅲ non - small cem ung cancer(NSCLC) :HOU LUN 01-24/USO- 023-Updated results[ J]. J Clin Oncol,2008,26(S) :7519.
  • 7andler AB, Gray R, Brahmer J, et al. Pactiltaxal-Carboplatin Alone or with Bevacizurnab for Non-Small-Cell lung Cancer [ J]. New England Journal of Medcine ,2006,355:2542-2250.
  • 8Hida T, Okamoto I, Kashii T, et al. Randomized phase Ⅲ study of platinum - doublet chemotherapy followed by gefitinib versus continued platinum-doublet chenotherapy in patient (pts) with advanced non-small cell lung cancer (NSCLC) :Results of West Japan Thoracic Oncology Group.trial ( WJTOG ) [ J ]. J Clin Oncol,2008,26 ( S ) : 8013.
  • 9Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomizd trial of docetaxel versus best supportive care in patieents with non-small-cell lung cancer previously teeated with platinu-based chemotherapy[J]. J Clin Oncol,2000,18:2095.
  • 10DouiUard J-Y, Hirsh V, Mok T, et al. Molecular and subgroup analyses from a phase Ⅲ trial comparing Gefitinib with docetaxel in previously terated non-small cell lung cancer[ J]. J Clin Oncol,2008,26(S) :8001.

同被引文献70

引证文献8

二级引证文献46

实用药物与临床
2009年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部